Centaur Pharmaceuticals Pvt. Ltd. is a fully integrated pharmaceutical company in India, excelling across various segments of the pharmaceutical value chain, including Active Pharmaceutical Ingredients (API), Research and Development (R&D), Contract Research and Manufacturing (CRAM), and clinical research. The company’s clinical research arm, LifeSan, is dedicated to providing comprehensive solutions that adhere to international regulatory standards. LifeSan specializes in Bioequivalence and Bioavailability (BA-BE) studies, as well as Phase II, III, and IV clinical trials, catering to both global leaders and prominent Indian firms. The facility is equipped with state-of-the-art machinery and staffed by experienced professionals, ensuring high-quality research outcomes.

One of Centaur's notable achievements is the co-development of a new chemical entity (NCE) known as DPOCL, aimed at treating Diabetic Foot Ulcer, a significant unmet medical need. This collaboration with CytoTools AG from Germany has successfully completed Phase II and III trials in India, positioning Centaur to potentially introduce this innovative treatment to the market, pending regulatory approval. LifeSan's capabilities extend to pharmacovigilance, further enhancing its role in the clinical research landscape. With India having the highest number of diabetics globally, the introduction of DPOCL represents a significant advancement in addressing this critical health issue.

India

Centaur Pharmaceuticals ranks among India’s few, fully integrated pharmaceutical firms with proficiencies across the pharmaceutical value chain. Centaur leverages its synergies across API, R&D, CRAM, Clinical Research and formulations to provide end-to-end solutions to prestigious pharmaceutical partners.

Centaur Pharmaceuticals Pvt. Ltd.

Company Details